Αρχική World News Cancer in My Community: Obstacles to Caring for People With Cancer in...

Cancer in My Community: Obstacles to Caring for People With Cancer in Rwanda

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with cancer in their region. Fidel Rubagumya, MD, MMed, is a clinical and radiation oncologist at Rwanda Military Hospital in Kigali, Rwanda, and a lecturer at the University of Global Health Equity in rural Rwanda. Dr. Rubagumya is an enthusiastic cancer advocate. He has been involved in many cancer control activities in Rwanda and internationally. He is the founder of Rwanda Children’s Cancer Relief (RCCR), an organization that raises awareness on childhood cancers. You can follow him on Twitter.

Why I care for people with cancer

At a young age, I lost someone close to me due to cancer. From that time forward, all I knew was that I wanted to become a doctor, and when I became one, all I wanted to do was to treat people with cancer. In Rwanda, most patients come in with late-stage cancer, especially due to system delays. For some, treatment works very well, and for others, unfortunately, it does not. But whatever the results, I call it a privilege to take a journey with these resilient people. Whether it’s days, months, or years, there is a bond, trust, and friendship that is created between me and them. There are times I know that treatment won’t help, and in those cases, we opt for pure supportive care. Later on, I may get a text or call saying, “They have passed on, but we wanted to thank you for being with us throughout, even when we knew cancer would take their life.” I think everyone wants to have someone supporting them during their difficult moments. I am happy that I am that person for my patients, and to some—and hopefully many more in the future—we come out with a happier conclusion.

What cancer is like in Rwanda

Cervical cancer and breast cancer are the most common cancers in Rwanda, with stomach cancer and prostate cancer also increasing each year. Not long ago, the country had no chemotherapy or radiation therapy services, and there were no specialists to treat cancers. Now, over the past decade, the country has the capacity to diagnose and treat cancers at 2 cancer centers in the country, as well as at other hospitals within Rwanda. We recently published “State of Cancer Control in Rwanda: Past, Present, and Future Opportunities” in JCO Global Oncology, which details the challenges to cancer care in Rwanda and our more recent achievements.

The challenges people with cancer face in Rwanda

In Rwanda, you find that patients and survivors are stigmatized due to either the cancer itself or due to the effects of cancer treatment. For example, those who have undergone a mastectomy for treatment of breast cancer may get divorced or be abandoned. Patient and survivor support groups would be very important for people with cancer in Rwanda, but we lack enough of these in our country. Patients, caregivers, and survivors also have many questions at appointments that treating oncologists often do not have enough time to answer, as there are few oncologists in Rwanda and the number of patients is increasing. There are a few patients, survivors, and oncologists who write about cancer and their experiences in the local newspapers, but these are not enough to help educate the people in our country.

Where patients can find local resources and support in Rwanda

Unfortunately, there are not enough local resources where people with cancer can find information. There are few nonprofit organizations that are involved in helping provide more information about cancer, as is often done in other countries. Similar to the lack of available cancer information, there are also not many organizations that provide non-clinical support to people with cancer and survivors. This is a real challenge, and I hope that people will be encouraged to take up this challenge to help those with cancer in Rwanda.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Avapritinib Not Superior to Regorafenib in Terms of Median PFS in Third-Line or Later Treatment of Patients with Unresectable or Metastatic GIST

Findings from an open-label, randomised, multicentre phase III VOYAGER study indicate that avapritinib is not superior to regorafenib in terms of median progression-free survival...

Patients less likely to rate cancer care as ‘very good’ during pandemic

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Whilst...

How to Avoid Spreading Harmful Chemo Chemicals to Members of Your Household

Cancer is not contagious, and neither is chemotherapy. However, harmful chemotherapy drugs can sometimes still be present in the bodily fluids of a person...

Can’t Sleep? Tips for Coping with Insomnia

Insomnia* is common for cancer patients**, as well as for the general population. We frequently hear from our patients and their caregivers that sleeping through the night...

New Task Force Focuses on Quality of Life for AYAs with Cancer

August 4, 2021, by NCI Staff Adolescents and young adults are using mobile devices to document the impact of cancer and its treatment on their...

Amivantamab Demonstrates Robust Efficacy in Patients with EGFR Exon 20 Insertion-Mutated NSCLC

Amivantamab demonstrated robust and durable responses in patients with epidermal growth factor receptor Exon 20 insertion (EGFR Exon20ins)-mutated non-small cell lung cancer (NSCLC) after progression on...